GlassScriptPhysician profile
Eric J Bass
NPI 1780765289
$3,364.77
in general payments reported to CMS, 2019-2025
12 companies · $410 in 2025
The $410 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $389 · 2020: $196 · 2021: $269 · 2022: $315 · 2023: $345 · 2024: $1,441 · 2025: $410.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,158 · Travel and Lodging: $987 · Entertainment: $51.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,157.71 |
| Travel and Lodging | $986.59 |
| Entertainment | $51.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,859.28 | 2019-2024 | Precision 1, Total30, Dailies Total1 |
| Coopervision INC. | $261.47 | 2019-2025 | Myday Contact Lens, Cvi Contact Lens |
| Abbvie INC. | $250.00 | 2022-2025 | |
| Sun Pharmaceutical Industries INC. | $249.91 | 2023 | Cequa |
| Bausch & Lomb Americas INC. | $136.85 | 2024-2025 | Alden Scleral Zenlens, Infuse, Btod |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $136.84 | 2019 | |
| Optos, INC. | $128.49 | 2019-2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Sight Sciences, INC. | $123.75 | 2021 | |
| Biotissue Holdings INC. | $99.32 | 2022 | |
| Abb Con-Cise Optical Group LLC | $67.26 | 2019 | |
| Visionix USA, INC | $41.67 | 2022 | |
| Johnson & Johnson Vision Care, INC. | $9.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Bass listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.